| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 253 | 265 | 57 | 172 | | Cost of Revenue | 141 | 60 |
-
|
-
| | | Gross Profit | 112 | 206 | 57 | 172 | | | Operating Expenses | | Research Development | 4,989 | 5,055 | 4,236 | 4,721 | | Selling General and Administrative | 2,652 | 2,202 | 2,539 | 2,064 | | Non Recurring | (546) | 340 | 205 | 485 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,983) | (7,391) | (6,924) | (7,098) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,866 | 53 | (2,330) | (2,959) | | Earnings Before Interest And Taxes | (5,117) | (7,337) | (9,253) | (10,057) | | Interest Expense | 28 | 29 | 28 | 26 | | Income Before Tax | (5,145) | (7,366) | (9,282) | (10,082) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,145) | (7,366) | (9,282) | (10,082) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,145) | (7,366) | (9,282) | (10,082) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,145) | ($7,366) | ($9,282) | ($10,082) |
|
0.11% Nasdaq 0.00%
Income Statement
